Evidence map›Paper›PMID 21347346›Full record

ArticlePLoS pathogens2011

BosR (BB0647) controls the RpoN-RpoS regulatory pathway and virulence expression in Borrelia burgdorferi by a novel DNA-binding mechanism.

Zhiming Ouyang, Ranjit K Deka, Michael V Norgard

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. TheInfection and immunity · 2026
    Article
  3. The BosR Is Back!Molecular microbiology · 2026
    Article
  4. Article
  5. Virulence Regulation inMicroorganisms · 2025
    Review
  6. Genomic Insights into Vector-Pathogen Adaptation inPathogens (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Infection and immunity · 2025
    Article
  11. Article
  12. Article
  13. Hitchhiker's Guide toJournal of bacteriology · 2024
    Review
  14. Article
  15. Article
  16. Chemotaxis Coupling Protein CheWInfection and immunity · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zhiming OuyangDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Ranjit K Deka
Michael V Norgard
The University of Texas Southwestern Medical Center · US

Funding

The RpoN-RpoS regulatory pathway in Borrelia burgdorferiR01AI059062 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI NORGARD, MICHAEL V. · 2004 to 2019
$6.2M
The RpoN-RpoS regulatory pathway in Borrelia burgdorferiR56AI059062 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI NORGARD, MICHAEL V. · 2009 to 2009
$323k
NIAID NIH HHS AI-059062NIAID NIH HHS R01 AI059062NIAID NIH HHS R56 AI059062
6 · The paper itself

Abstract

In Borrelia burgdorferi (Bb), the Lyme disease spirochete, the alternative σ factor σ⁵⁴ (RpoN) directly activates transcription of another alternative σ factor, σ(S) (RpoS) which, in turn, controls the expression of virulence-associated membrane lipoproteins. As is customary in σ⁵⁴-dependent gene control, a putative NtrC-like enhancer-binding protein, Rrp2, is required to activate the RpoN-RpoS pathway. However, recently it was found that rpoS transcription in Bb also requires another regulator, BosR, which was previously designated as a Fur or PerR homolog. Given this unexpected requirement for a second activator to promote σ⁵⁴-dependent gene transcription, and the fact that regulatory mechanisms among similar species of pathogenic bacteria can be strain-specific, we sought to confirm the regulatory role of BosR in a second virulent strain (strain 297) of Bb. Indeed, BosR displayed the same influence over lipoprotein expression and mammalian infectivity for strain Bb 297 that were previously noted for Bb strain B31. We subsequently found that recombinant BosR (rBosR) bound to the rpoS gene at three distinct sites, and that binding occurred despite the absence of consensus Fur or Per boxes. This led to the identification of a novel direct repeat sequence (TAAATTAAAT) critical for rBosR binding in vitro. Mutations in the repeat sequence markedly inhibited or abolished rBosR binding. Taken together, our studies provide new mechanistic insights into how BosR likely acts directly on rpoS as a positive transcriptional activator. Additional novelty is engendered by the facts that, although BosR is a Fur or PerR homolog and it contains zinc (like Fur and PerR), it has other unique features that clearly set it apart from these other regulators. Our findings also have broader implications regarding a previously unappreciated layer of control that can be involved in σ⁵⁴-dependent gene regulation in bacteria.

Indexed as

Gene Expression Regulation, BacterialAnimalsBacterial ProteinsBase SequenceBorrelia burgdorferiDNA, BacterialDNA-Binding ProteinsGenes, RegulatorLyme DiseaseMiceMolecular Sequence DataOrganisms, Genetically ModifiedProtein BindingRecombinant ProteinsRepressor ProteinsRNA Polymerase Sigma 54Bacterial ProteinsDNA, BacterialDNA-Binding Proteinsperoxide repressor proteinsRecombinant ProteinsRepressor ProteinsRNA Polymerase Sigma 54Sigma Factorsigma factor KatF protein, Bacteria

Identifiers

PMID21347346
PMCPMC3037356
OpenAlexW2049296526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.